How big is the postoperative pain market?
The postoperative pain market reached a value of US$ 2,440 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 5,248.7 Million by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2023-2033.
The report offers a comprehensive analysis of the postoperative pain market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the postoperative pain market.
Request for a Sample of this Report: https://www.imarcgroup.com/postoperative-pain-market/requestsample
The market for postoperative pain is experiencing significant growth, fueled by an amalgamation of factors that range from medical advancements to changing healthcare policies. One of the main market drivers is the increase in the number of surgical procedures on account of an aging population and the elevating incidence of chronic diseases. More surgeries naturally translate to higher demand for postoperative pain management solutions, pushing the market upward. The market has also witnessed a surge due to technological advancements in pain management solutions. The advent of smarter infusion pumps, long-acting analgesics, and minimally invasive surgical techniques contributes to effective pain management, making these options more appealing to both physicians and patients. FDA approvals for new drugs and therapies are expediting market growth by providing medical professionals with more options for postoperative pain management. These approved solutions often have fewer side effects and contraindications, making them more desirable in postoperative settings.
Patient awareness about effective postoperative pain management options has risen due to the information age. The empowered patient is more likely to discuss and demand better pain management solutions, which, in turn, drives healthcare providers to adopt advanced technologies and medications. Shifting healthcare policies are also playing a role. Reimbursement frameworks that include the costs of postoperative pain management contribute to increased adoption rates among hospitals. Conversely, healthcare providers are under increased scrutiny to reduce hospital readmissions and enhance patient satisfaction, both of which are influenced by effective postoperative pain management. The ongoing opioid crisis is forcing the healthcare industry to look for safer, non-addictive pain management alternatives. This has led to increased R&D investments in this area, further propelling postoperative pain market growth.
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the postoperative pain market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the postoperative pain market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current postoperative pain marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape With Key Players:
The competitive landscape of the postoperative pain market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the Key Players:
- Innocoll
- Baudax Bio
- Omeros Corporation
- Astrazeneca
- AbbVie
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=6776&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/